The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance
Abstract
Because of the emergence of antibiotic-resistant pathogens worldwide, a number of infectious diseases have become difficult to treat. This threatening situation is worsened by the fact that very limited progress has been made in developing new and potent antibiotics in recent years. However, a group of antimicrobials, the so-called bacteriocins, have been much studied lately because they hold a great potential in controlling antibiotic-resistant pathogens. Bacteriocins are small antimicrobial peptides (AMPs) produced by numerous bacteria. They often act toward species related to the producer with a very high potency (at pico- to nanomolar concentration) and specificity. The common mechanisms of killing by bacteriocins are destruction of target cells by pore formation and/or inhibition of cell wall synthesis. Several studies have revealed that bacteriocins display great potential in the medical sector as bacteriocinogenic probiotics and in the clinic as therapeutic agents. In this review, we discuss the emerging antibiotic resistance and strategies to control its dissemination, before we highlight the potential of AMPs from bacteria as a new genre of antimicrobial agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common mechanisms used by bacteriocins to kill other microorganisms include the formation of pores in the cell membrane or the inhibition of cell wall synthesis [186].”
From Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions (2022) · cites this paper as [186]
In the citing paper
“Several studies have shown that the use of bacteriocin-producing bacteria is more effective than purified bacteriocins in improving gut health [186].”
From Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions (2022) · cites this paper as [186]
Citations
Cites
Bacteriocins of gram-positive bacteria
Jack, R. W., Tagg, J. R., & Ray, B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.2.171-200.1995 · Cited by 2,711
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria
Postma, P. W., Lengeler, J. W., & Jacobson, G. R. (1993) · Microbiological Reviews · doi:10.1128/mr.57.3.543-594.1993 · Cited by 1,802
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A. S., Soper, P., McKaigney, C. J., Jijon, H. B., Yachimec, C., Doyle, J. S. G., Jewell, L. D., & Simone, C. D. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,096
Dufès, C., Uchegbu, I. F., & Schätzlein, A. G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., & Gahan, C. G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700440104 · Cited by 853
Wiedemann, I., Breukink, E. J., van Kraaij, C., Kuipers, O. P., Bierbaum, G., KRUIJFF, B. D., & Sahl, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 793
Handbook of Biologically Active Peptides
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-369442-3.x5001-6 · Cited by 720
Bacteriocins from lactic acid bacteria: Production, purification, and food applications
De Vuyst, L., & Leroy, F. (2007) · Microbial Physiology · doi:10.1159/000104752 · Cited by 708
Research works printed but not linked: 2
- Bonelli, 2006, Lantibiotics, including nisin, 1139
- Rea, 2010b, Microbes and Health Sackler Colloquium: effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon, Proc Natl Acad Sci USA, 15, 4639
Cited by
Sorted by citations
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 2,020
Probiotic Mechanisms of Action
Bermúdez-Brito, M., Plaza‐Díaz, J., Muñoz‐Quezada, S., Gómez‐Llorente, C., & Gil, Á. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000342079 · Cited by 1,326
Simons, A., Alhanout, K., & Duval, R. E. (2020) · Microorganisms · doi:10.3390/microorganisms8050639 · Cited by 587
Escherichia coli in Europe: An Overview
Allocati, N., Masulli, M., ALEXEYEV, M. F., & Ilio, C. D. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10126235 · Cited by 481
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Büyükkiraz, M. E., & Kesmen, Z. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15314 · Cited by 457
Metadata
- Authors
- Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F.
- Affiliations
- Zanjan University of Medical Sciences (IR)
- Norwegian University of Life Sciences (NO)
- Tabriz University of Medical Sciences (IR)
- Corresponding author
- Lotfipour, F.
- Venue
- Journal of Applied Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-08
- Volume
- 113
- Issue
- 4
- Pages
- 723-736
- ISSN
- 1364-5072 (ISSN-L)
- OpenAlex
- W2132437761
- Cited by
- 402
- References
- 135
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 32 · 2023: 32 · 2022: 42 · 2021: 35 · 2020: 45 · 2019: 34 · 2018: 29 · 2017: 29 · 2016: 23 · 2015: 28 · 2014: 21 · 2013: 13 · 2012: 7
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Applied Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- antimicrobial peptides, bacteriocins, antibiotic resistance, antibiotic-resistant pathogens, pore formation, cell wall synthesis inhibition, natural antimicrobials
- MeSH terms
- Bacteria, Bacteriocins, Peptides, Probiotics, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
